Monocytes contribute to differential immune pressure on R5 versus X4 HIV through the adipocytokine visfatin/nampt

PLoS ONE

Volumn 7, Issue 4, 2012, Pages

  van den Bergh, Rafael ^a,b   Morin, Sébastien ^c   Sass, Hans Jürgen ^c   Grzesiek, Stephan ^c   Vekemans, Marc ^d   Florence, Eric ^d   Tran, Huyen Thanh Thi ^a,b   Imiru, Rosina Gabriel ^a,b,d   Heyndrickx, Leo ^d   Vanham, Guido ^d,e   de Baetselier, Patrick ^a,b   Raes, Geert ^a,b  

^a DEPARTMENT OF PLANT SYSTEMS BIOLOGY   (Belgium)

^b VRIJE UNIVERSITEIT BRUSSEL   (Belgium)

^c UNIVERSITY OF BASEL   (Switzerland)

^d INSTITUTE OF TROPICAL MEDICINE   (Belgium)

^e UNIVERSITY OF ANTWERP   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR CCR5; MESSENGER RNA; NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE; VIRUS DNA; CHEMOKINE RECEPTOR CXCR4;

ARTICLE; BINDING AFFINITY; BINDING SITE; CELL VIABILITY; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS; IN VITRO STUDY; INNATE IMMUNITY; INTERMETHOD COMPARISON; MONOCYTE; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PREDICTION; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; VIRUS CELL INTERACTION; VIRUS ISOLATION; VIRUS REPLICATION; BIOSYNTHESIS; CELL CULTURE; DRUG EFFECT; ENZYMOLOGY; GENETIC SELECTION; GENETICS; HOST PATHOGEN INTERACTION; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOLOGY; METABOLISM; SECRETION; SPECIES DIFFERENCE; SURFACE PLASMON RESONANCE; VIROLOGY;

CELLS, CULTURED; HIV; HIV INFECTIONS; HOST-PATHOGEN INTERACTIONS; HUMANS; IMMUNITY, INNATE; MONOCYTES; NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE; RECEPTORS, CCR5; RECEPTORS, CXCR4; SELECTION, GENETIC; SPECIES SPECIFICITY; SURFACE PLASMON RESONANCE; VIRUS REPLICATION;

EID: 84859514605     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0035074     Document Type: Article

References (44)

1. Lemey P, Rambaut A, Pybus OG, (2006) HIV evolutionary dynamics within and among hosts. AIDS Rev 8: 125-140.
2. Hartley O, Klasse PJ, Sattentau QJ, Moore JP, (2005) V3: HIV's switch-hitter. AIDS Res Hum Retroviruses 21: 171-189.
3. Regoes RR, Bonhoeffer S, (2005) The HIV coreceptor switch: a population dynamical perspective. Trends Microbiol 13: 269-277.
4. Moore JP, Kitchen SG, Pugach P, Zack JA, (2004) The CCR5 and CXCR4 coreceptors--central to understanding the transmission and pathogenesis of human immunodeficiency virus type 1 infection. AIDS Res Hum Retroviruses 20: 111-126.
5. McMichael AJ, Phillips RE, (1997) Escape of human immunodeficiency virus from immune control. Annu Rev Immunol 15: 271-296.
6. Moore CB, John M, James IR, Christiansen FT, Witt CS, et al. (2002) Evidence of HIV-1 adaptation to HLA-restricted immune responses at a population level. Science 296: 1439-1443.
7. Kawashima Y, Pfafferott K, Frater J, Matthews P, Payne R, et al. (2009) Adaptation of HIV-1 to human leukocyte antigen class I. Nature 458: 641-645.
8. Richman DD, Wrin T, Little SJ, Petropoulos CJ, (2003) Rapid evolution of the neutralizing antibody response to HIV type 1 infection. Proc Natl Acad Sci U S A 100: 4144-4149.
9. Wei X, Decker JM, Wang S, Hui H, Kappes JC, et al. (2003) Antibody neutralization and escape by HIV-1. Nature 422: 307-312.
10. Wiley CA, Schrier RD, Nelson JA, Lampert PW, Oldstone MB, (1986) Cellular localization of human immunodeficiency virus infection within the brains of acquired immune deficiency syndrome patients. Proc Natl Acad Sci U S A 83: 7089-7093.
11. Crowe S, Mills J, McGrath MS, (1987) Quantitative immunocytofluorographic analysis of CD4 surface antigen expression and HIV infection of human peripheral blood monocyte/macrophages. AIDS Res Hum Retroviruses 3: 135-145.
12. Kedzierska K, Crowe SM, (2002) The role of monocytes and macrophages in the pathogenesis of HIV-1 infection. Curr Med Chem 9: 1893-1903.
13. Montaner LJ, Crowe SM, Aquaro S, Perno CF, Stevenson M, et al. (2006) Advances in macrophage and dendritic cell biology in HIV-1 infection stress key understudied areas in infection, pathogenesis, and analysis of viral reservoirs. J Leukoc Biol 80: 961-964.
14. Wahl SM, Orenstein JM, (1997) Immune stimulation and HIV-1 viral replication. J Leukoc Biol 62: 67-71.
15. Gordon SB, Read RC, (2002) Macrophage defences against respiratory tract infections. Br Med Bull 61: 45-61.
16. Jones G, Power C, (2006) Regulation of neural cell survival by HIV-1 infection. Neurobiol Dis 21: 1-17.
17. Aquaro S, Bagnarelli P, Guenci T, De Luca A, Clementi M, et al. (2002) Long-term survival and virus production in human primary macrophages infected by human immunodeficiency virus. J Med Virol 68: 479-488.
18. Carr JM, Hocking H, Li P, Burrell CJ, (1999) Rapid and efficient cell-to-cell transmission of human immunodeficiency virus infection from monocyte-derived macrophages to peripheral blood lymphocytes. Virology 265: 319-329.
19. Kamp C, (2009) Understanding the HIV coreceptor switch from a dynamical perspective. BMC Evol Biol 9: 274.
20. Van den Bergh R, Florence E, Vlieghe E, Boonefaes T, Grooten J, et al. (2010) Transcriptome analysis of monocyte-HIV interactions. Retrovirology 7: 53.
21. Friebe D, Neef M, Kratzsch J, Erbs S, Dittrich K, et al. (2011) Leucocytes are a major source of circulating nicotinamide phosphoribosyltransferase (NAMPT)/pre-B cell colony (PBEF)/visfatin linking obesity and inflammation in humans. Diabetologia 54: 1200-1211.
22. Van Herrewege Y, Penne L, Vereecken C, Fransen K, van der Groen G, et al. (2002) Activity of reverse transcriptase inhibitors in monocyte-derived dendritic cells: a possible in vitro model for postexposure prophylaxis of sexual HIV transmission. AIDS Res Hum Retroviruses 18: 1091-1102.
23. Beirnaert E, Willems B, Peeters M, Bouckaert A, Heyndrickx L, et al. (1998) Design and evaluation of an in-house HIV-1 (group M and O), SIVmnd and SIVcpz antigen capture assay. J Virol Methods 73: 65-70.
24. Reed LJ, Muench H, (1938) A simple method of estimating fifty percent endpoints. Am J Hyg 27: 493-497.
25. Jiang S, Lu H, Liu S, Zhao Q, He Y, et al. (2004) N-substituted pyrrole derivatives as novel human immunodeficiency virus type 1 entry inhibitors that interfere with the gp41 six-helix bundle formation and block virus fusion. Antimicrob Agents Chemother 48: 4349-4359.
26. Weber J, Weberova J, Carobene M, Mirza M, Martinez-Picado J, et al. (2006) Use of a novel assay based on intact recombinant viruses expressing green (EGFP) or red (DsRed2) fluorescent proteins to examine the contribution of pol and env genes to overall HIV-1 replicative fitness. J Virol Methods 136: 102-117.
27. Graham FL, Smiley J, Russell WC, Nairn R, (1977) Characteristics of a human cell line transformed by DNA from human adenovirus type 5. J Gen Virol 36: 59-74.
28. Van Herrewege Y, Morellato L, Descours A, Aerts L, Michiels J, et al. (2008) CD4 mimetic miniproteins: potent anti-HIV compounds with promising activity as microbicides. J Antimicrob Chemother 61: 818-826.
29. Weiss A, Wiskocil RL, Stobo JD, (1984) The role of T3 surface molecules in the activation of human T cells: a two-stimulus requirement for IL 2 production reflects events occurring at a pre-translational level. J Immunol 133: 123-128.
30. Smith SD, Shatsky M, Cohen PS, Warnke R, Link MP, et al. (1984) Monoclonal antibody and enzymatic profiles of human malignant T-lymphoid cells and derived cell lines. Cancer Res 44: 5657-5660.
31. Nisius L, Rogowski M, Vangelista L, Grzesiek S, (2008) Large-scale expression and purification of the major HIV-1 coreceptor CCR5 and characterization of its interaction with RANTES. Protein Expr Purif 61: 155-162.
32. Navratilova I, Sodroski J, Myszka DG, (2005) Solubilization, stabilization, and purification of chemokine receptors using biosensor technology. Anal Biochem 339: 271-281.
33. Navratilova I, Dioszegi M, Myszka DG, (2006) Analyzing ligand and small molecule binding activity of solubilized GPCRs using biosensor technology. Anal Biochem 355: 132-139.
34. Pillai S, Good B, Richman D, Corbeil J, (2003) A new perspective on V3 phenotype prediction. AIDS Res Hum Retroviruses 19: 145-149.
35. Korner A, Garten A, Bluher M, Tauscher R, Kratzsch J, et al. (2007) Molecular characteristics of serum visfatin and differential detection by immunoassays. J Clin Endocrinol Metab 92: 4783-4791.
36. Arien KK, Gali Y, El-Abdellati A, Heyndrickx L, Janssens W, et al. (2006) Replicative fitness of CCR5-using and CXCR4-using human immunodeficiency virus type 1 biological clones. Virology 347: 65-74.
37. Jones KL, Roche M, Gantier MP, Begum NA, Honjo T, et al. (2010) X4 and R5 HIV-1 have distinct post-entry requirements for uracil DNA glycosylase during infection of primary cells. J Biol Chem 285: 18603-18614.
38. Oswald-Richter K, Grill SM, Leelawong M, Tseng M, Kalams SA, et al. (2007) Identification of a CCR5-expressing T cell subset that is resistant to R5-tropic HIV infection. PLoS Pathog 3: e58.
39. Vyakarnam A, Eyeson J, Teo I, Zuckerman M, Babaahmady K, et al. (2001) Evidence for a post-entry barrier to R5 HIV-1 infection of CD4 memory T cells. Aids 15: 1613-1626.
40. Moncunill G, Armand-Ugon M, Pauls E, Clotet B, Este JA, (2008) HIV-1 escape to CCR5 coreceptor antagonism through selection of CXCR4-using variants in vitro. Aids 22: 23-31.
41. Sguanci L, Bagnoli F, Lio P, (2007) Modeling HIV quasispecies evolutionary dynamics. BMC Evol Biol 7 (Suppl 2): S5.
42. Bewick S, Wu J, Lenaghan SC, Yang R, Zhang M, et al. (2011) The R5 to X4 Coreceptor Switch: A Dead-End Path, or a Strategic Maneuver? Lessons from a Game Theoretic Analysis. Bull Math Biol.
43. Sonoli SS, Shivprasad S, Prasad CV, Patil AB, Desai PB, et al. (2011) Visfatin--a review. Eur Rev Med Pharmacol Sci 15: 9-14.
44. Moschen AR, Gerner RR, Tilg H, (2010) Pre-B cell colony enhancing factor/NAMPT/visfatin in inflammation and obesity-related disorders. Curr Pharm Des 16: 1913-1920.